Preservation of fat-free mass in the first year after bariatric surgery: a systematic review and meta-analysis of 122 studies and 10,758 participants
With muscle preservation during GLP-1 therapy being a major concern, retatrutide's glucagon component is of particular interest
Oral semaglutide can be used as a treatment intensification option even in addition to insulin.[] PIONEER 5 was a randomized, double-blind, placebo-controlled, parallel-group, multicentre, multinational trial that included 324 subjects with T2DM and estimated glomerular filtration rate (eGFR) 3059 mL/min/1.73 m 2 , on stable doses of 12 oral antidiabetic drugs (OADs) (metformin, SU) and/or basal insulin for 90 days randomized to oral semaglutide 14 mg and placebo (1:1)
J.TorresM
Quebec, Ontario, and British Columbia have different coverage policies that impact out-of-pocket costs
Nucleic acid-based therapeutics for the treatment of central nervous system disorders